SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Biocept Inc. is hoping to raise $5 million in an offering of its common stock, the company announced April 29.
San Diego’s Ignyta Inc., a drugmaker developing cancer therapeutics, is hoping to raise $50 million in an offering of its common stock, the company announced Wednesday.
PHARMA: New Painkiller And Other Drugs Being Tested
It’s been a rocky year for Arena Pharmaceuticals Inc., but things are looking up with its latest experimental drug: a painkiller that mimics cannabis without the head high.
Dexcom Inc., one of San Diego’s biggest public medical technology firms, reported a 60 percent jump in revenue for the first quarter of this year.
San Diego medical device company ResMed Inc. reported a drop in net income for the first quarter of 2016.
San Diego medical device maker NuVasive Inc. exceeded Wall Street expectations Tuesday when it reported a boost in revenue and an improved bottom line.
Millennium Health, a drug-testing firm in San Diego, announced that Chairman of the Board Ronald Rittenmeyer is taking over as CEO.
A month after abruptly firing two top executives, San Diego’s cancer test company Trovagene Inc. has appointed a new CEO.
BIOTECH: Co. Emerges With Anti-Aging Results; Some in Industry Are Skeptical
Osman Kibar is nonchalant, as billionaires go, but he’s nothing if not confident. Dressed in a fading polo shirt and old jeans, he leans back in his chair, intertwines his fingers and fights a knowing smile. He knows why I’m here.
San Diego’s Human Longevity Inc. struck a deal with pharma giant AstraZeneca and its global biologics R&D arm, MedImmune, the companies announced April 21.
San Diego medtech Skylit Medical raised fresh capital this week and added two board members.
San Diego County Medical Society Foundation has rebranded, changing its name to Champions for Health.
One of San Diego’s top research facilities has partnered with pharma giant GlaxoSmithKline to form a new center focused on neuroscience in La Jolla.
A weak earnings forecast driven by disappointing sales in Europe hammered shares of San Diego-based Illumina Inc. during trading Tuesday and Wednesday.
Healthcare education provider Pima Medical Institute has signed a long-term lease for a space at the North City mixed-use development in San Marcos, the project’s developer announced.